Consistent with these observations, STXBP2/Syntaxin-11-deficient patients develop FHL slightly later than those who harbor mutations in non-redundant proteins, perforin, or Munc13-4 (7, 8). This evidence concerns the gene STX11 and hemophagocytic syndrome.